Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viatris Inc
(NQ:
VTRS
)
11.75
-0.01 (-0.09%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viatris Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Got $5,000? These 2 Dividend Stocks Are Dirt Cheap Buys
September 02, 2021
And their yields are both over 3%.
Via
The Motley Fool
3 Things About Pfizer That Smart Investors Know
August 31, 2021
They're all about the future.
Via
The Motley Fool
Theravance Stock Crashes; Can Longer Testing Salvage Its J&J-Partnered Drug?
August 24, 2021
Theravance said late Monday its ulcerative colitis treatment failed in midstage testing, and the biotech stock plummeted early Tuesday.
Via
Investor's Business Daily
3 Top Biotech Stocks to Buy in August
August 17, 2021
Each of these companies makes for a great vehicle to play an aging demographic.
Via
The Motley Fool
Analysts Love This Newly Formed Healthcare Company; Should You?
August 16, 2021
Viatris' steady operating results and cheap valuation are two key reasons for its high one-year price target.
Via
The Motley Fool
Unusual Options Activity Insight: Viatris
August 09, 2021
On Monday, shares of Viatris (NASDAQ:VTRS) saw unusual opt...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For May 10, 2021
May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...
Via
Benzinga
Viatris Inc (VTRS) Q2 2021 Earnings Call Transcript
August 09, 2021
VTRS earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
How This Historic FDA Approval Benefits Viatris
August 04, 2021
Here's what the FDA's approval of Semglee, from Viatris and Biocon, means for the former.
Via
The Motley Fool
Exposures
Product Safety
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For August 9, 2021
August 09, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...
Via
Benzinga
Viatris Stock Gains After FDA Approves Viatris-Biocon Biologics' Insulin Glargine Biosimilar Injection
July 29, 2021
The FDA cleared Viatris inc (NASDAQ: VTRS) - Biocon Biologics' Semglee insulin glargine-yfgn injection as a biosimilar. Semglee indicates controlling high...
Via
Benzinga
Exposures
Product Safety
How To Find Value Stocks July 2021
July 21, 2021
Identifying fair value in an inflated stock market is really important, because in all markets, whether bull or bear you can always find value.
Via
Talk Markets
10 Worst Performing S&P 500 Stocks Of 2021
July 02, 2021
The S&P 500 has continued its late-2020 momentum in the first two quarters of the year, gaining more than 15% year-to-date. Most U.S. investors have had a lot of winners in...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Viatris Stock Rocketed Higher in May
June 08, 2021
This undervalued dividend stock finally found its footing in May.
Via
The Motley Fool
2 Best Value Stocks to Buy Now
May 31, 2021
Looking for solid companies trading on the cheap? Here are your top bets!
Via
The Motley Fool
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
June 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
2 Healthcare Stocks That Could Be Millionaire-Makers
May 30, 2021
The combination of stability and innovation makes these giants safe bets for long-term returns.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...
Via
Benzinga
Is Viatris a Good Stock to Buy for 2021?
May 30, 2021
Long-term investors might want to consider adding this recently formed pharmaceutical company to their portfolios.
Via
The Motley Fool
Why Is No One Talking About Viatris Stock?
May 27, 2021
This company is one of the largest manufacturers of generic pharmaceuticals in the world, but it may be underpriced.
Via
The Motley Fool
Not Just GameStop, WallStreetBets' Target Melvin Capital Closed All Public Short Positions In Q1
May 19, 2021
Hedge fund Melvin Capital Management LP, which was at the heart of the GameStop Corp. (NYSE: GME) short squeeze frenzy earlier this year, closed out of all its public short...
Via
Benzinga
Viatris Inc (VTRS) Q1 2021 Earnings Call Transcript
May 10, 2021
VTRS earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Viatris Q1 Sales Tops Estimates, Reaffirms 2021 Outlook, Announces Quarterly Dividend
May 10, 2021
Viatris Inc (NASDAQ: VTRS) reported Q1 net sales of $4.4 billion, down 6% Y/Y on a reported basis, but only down 2% compared to a combined loss of exclusivity...
Via
Benzinga
Is Generic-Drug Maker Viatris a Keeper?
May 09, 2021
It depends on what type of investor you are.
Via
The Motley Fool
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
Cramer Shares His Thoughts On JetBlue, General Electric And More
April 30, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he is an EV guy, but you have got to pick which EV you want. He prefers Tesla, Inc. (NASDAQ: TSLA) over...
Via
Benzinga
Wall Street Thinks This Dirt-Cheap Stock Will Soar 50%
April 26, 2021
But that's not the best reason to consider buying it.
Via
The Motley Fool
3 Best Value Stocks to Buy Now
April 14, 2021
On the hunt for bargains in today's overvalued market? Look no further.
Via
The Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.